自从20世纪70年代禾草灵(diclofop)投放市场以来,针对靶标为乙酰辅酶A羧化酶的抑制剂设计合成的品种有两大类,芳氧苯氧丙酸酯(APP)和环己二酮类(CHD),以及近年先正达投放市场的以唑啉草酯为代表的新颖结构品种,目前40年来相继有20余个品种上市。如拜耳公司开发的噁唑禾草灵(fenoxaporp)和先正达开发的三甲 Since diclofop was introduced to the market in the 1970s, there are two broad categories of products designed and synthesized for inhibitors targeting acetyl-CoA carboxylase, which are classified as APP and cyclohexyl Ketones (CHD), as well as Syngenta on the market in recent years to the new structure represented by pinoxatilis varieties, the current 40 years have been more than 20 varieties listed. Such as the fenoxaporp developed by Bayer and the top three developed by Syngenta